Proven Results: Clinical studies and patient stories show significant improvements in sexual desire, satisfaction, and confidence with mild, manageable side effects
Numerous clinical trials have demonstrated that saffron possesses antidepressant properties comparable to those of conventional antidepressant medications like fluoxetine, imipramine, and citalopram
Main limitation: selectivity figures (such as an in-vitro ~11.7-fold preference for senescent cells) come from cell models, not humans
While p53 modulators, including FOXO4-DRI, MDM2 inhibitors, and USP7 inhibitors have shown senolytic effects by selectively eliminating senescent cells or promoting their apoptosis in the laboratory, translating these findings to the clinic have so far been unsuccessful
Third, cardiovascular safety assessment meeting post-2008 FDA guidance for metabolic drugs, likely requiring a dedicated CV outcomes trial or extended observation period 23
it offers semaglutide and tirzepatide through its own Weight Management Protocols, and this piece compares approaches within the GLP-1 telehealth space
